Athenex, Inc. (ATNX) Misled Investors About the Efficacy of its Lead Drug Candidate and the Likelihood the FDA Would Approve its New Drug Application On August 7, 2019, Athenex, Inc.

RenovaCare, Inc. (RCAR) Charged with Securities Fraud   According to a class action complaint filed on behalf of RenovaCare, Inc. shareholders, on May 28, 2021, the SEC issued a release

Embark Technology, Inc. (EMBK) Criticized as Being “More Bark than Bite”   Robbins LLP is investigating Embark Technology, Inc. (NASDAQ: EMBK) to determine whether certain Embark officers and directors violated

Applied Therapeutics, Inc. (APLT) Holds Submission of New Drug Application for AT-007 Applied Therapeutics Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, Galactosemia, and diabetic complications.

Laboratory Corporation of America Holdings’ (LH) Prenatal Tests May be Inaccurate On January 1, 2022, an article from the New York Times called into question the accuracy of certain noninvasive

Meta Materials Inc. (MMAT) Misled Investors Regarding its Business Prospects   A shareholder filed a class action on behalf of all persons who purchased or otherwise acquired the publicly traded

Natera, Inc.’s (NTRA) Prenatal Tests May be Inaccurate Up to 85% of the Time On January 1, 2022, an article from the New York Times called into question the accuracy

Clarivate Plc (CLVT) Made Financial Misstatements On December 27, 2021, Clarivate disclosed in a filing with the U.S. Securities and Exchange Commission that “[o]n December 22, 2021, Clarivate .. .

Zillow Group, Inc. (Z, ZG) Misled Investors Regarding its Ability to Forecast Home Prices for its Zillow Offers Business A class action was filed on behalf of all persons and